Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cronos Group

Aurora Cannabis

Aphria

Curaleaf Holdings, Inc.

HEXO Corp

CRON stock stands to gain from state-level cannabis legalization as well as from speculation around federal legalization. The post Cronos Group and Other Cannabis Stocks Could See Higher Highs appeared first on InvestorPlace.

Cronos Group and Other Cannabis Stocks Could See Higher Highs

Canopy Growth holds conditional ownership of approximately 20% in TerrAscend SMITHS FALLS, ON, Feb. 23, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC) announces that it has closed the previously announced plan of arrangement under the Business...

Canopy Growth Announces Closing of Plan of Arrangement Involving RIV Capital

Canopy Growth bled money again in the last quarter as Multi-State Operators posted profits, suggesting the latter is a better investment. The post Sell Canopy Growth Stock Right Now, and Buy It Back Cheaper in August appeared first on InvestorPlace.

Sell Canopy Growth Stock Right Now, and Buy It Back Cheaper in August

Tilray Brands

The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannabis space with several potential catalysts of note ahead.

4 Things Cannabis Investors Should Watch This Week

CGC stock and other cannabis names are on the rise with Democrats taking Congress and the White House. But you'll need to be patient.

Your Patience Will Pay Off With Canopy Growth Stock

SNDL Inc.

Marijuana stocks have outpaced the broader market so far this year and the gains could continue as retail investors pile in. The post 4 Marijuana Stocks That Are Surging appeared first on InvestorPlace.

4 Marijuana Stocks That Are Surging

They're slowly becoming the rock-solid businesses he favors.

2 Hot Marijuana Stocks Even Warren Buffett Might Want to Buy in 2021

This isn't even close to a difficult decision.

Forget Sundial Growers, Canopy Growth Is a Better Marijuana Stock

The company is getting out of the venture capital business.

Why Canopy Growth Popped 5.4% Higher Today

The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jessica Rabe discussed what drove the early 2021 cannabis stock rally and three reasons why it has run out of steam in the past two weeks.

3 Reasons Cannabis Stocks May Be Headed Lower

Arena Pharmaceuticals

GW Pharmaceuticals

New Age Beverages

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

9 Red-Hot Cannabis Stocks Blazing This Week

Amplify Seymour Cannabis ETF

Jazz Pharmaceuticals

Amplify Alternative Harvest ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Should You Invest in Marijuana Stocks & ETFs Now?

TORONTO, Feb. 18, 2021 /PRNewswire/ - Canopy Rivers Inc. ("Rivers" or the "Company") today announced that the Ontario Superior Court of Justice (Commercial List) has approved the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy...

Rivers Obtains Court Approval of the Arrangement with Canopy Growth

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

U.S. companies are overlooked by many investors. But any state and federal legalization favors them over Canadian rivals, fund managers say.

Cannabis Watch: If you want to get rich with marijuana stocks, you need to know the crucial difference between U.S. and Canadian companies

And if you believe him, you'll probably want to buy the stock right now.

Canopy Growth's CEO Has 2 Bold New Predictions

Investors are more excited than they should be about a big deal this company has engineered.

1 Marijuana Stock to Avoid Like the Plague

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

Canadian cannabis stocks have surged in 2021 and a few of them have exhibited irrational exuberance such as Tilray and Sundial. U.S. cannabis stocks continue to trade at a substantial discount despite possessing significantly stronger fundamentals.

Tilray, Sundial May Be In A Bubble But This Group Remains Attractive

AMC Entertainment

BlackBerry

GameStop

PayPal

Meme stocks can be hard to time. But one thing is clear -- they will dominate the news in 2021.

Meme Stock Predictions for 2021: Where Will GME, BB, AMC and Bitcoin Go?

CGC stock is not longer as frothy as it was two years ago. Its long-term thesis is viable so it's a matter of timing entry cautiously.

Canopy Growth Still Holds the Same Potential

We've seen this story before, and it didn't end well for pot stock investors on the first go-round.

Marijuana Stock Bubble 2.0 Is Here

Greenlane Holdings

FSD Pharma

Innovative Industrial Properties

Akerna Corp

Cannabis Stocks Felt the Reddit Rumble This Week

Altria

Constellation Brands

The sector is hot again on the heels of two large deals.

Will There Be More M&A for the Cannabis Industry in 2021?

Marijuana stocks have moved higher as hopes increase for wider U.S. legalization, but fell sharply on Feb. 11. Are any pot stocks good buys?

Are Any Marijuana Stocks Good Buys After Wild Swings?

Cannabis stocks took a nosedive on Thursday with many of the sector's best performers a day earlier surrendering those gains, as the relentless buying in recent weeks amid growing hopes for reforms of strict U.S. laws came to a screeching halt.

Cannabis Watch: Cannabis stocks nosedive as rally driven by hopes for U.S. reforms comes to a screeching halt

Canopy Growth is sprinting into hypergrowth mode, so ignore the near-term volatility and buy the dip in CGC stock. The post Canopy Growth Is Ready for the Big Leagues, So Buy the Dip in CGC Stock appeared first on InvestorPlace.

Canopy Growth Is Ready for the Big Leagues, So Buy the Dip in CGC Stock

News for Canopy Growth Stock (CGC)